Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing was lodged with Hong Kong Exchanges and Clearing Limited on 8 April 2026.

Authorised Capital • The company’s authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.

Issued Shares and Treasury Position • Issued ordinary shares stood unchanged at 1.32 billion. • No treasury shares were held or created, keeping total issued shares at 1.32 billion.

Public Float Compliance • Bayzed Health confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 March 2026.

Share Option Scheme Activity • The post-IPO share option scheme adopted on 8 August 2023 (amended 9 June 2025) reported zero outstanding, granted, or exercised options, resulting in no new share issuances or fund inflows.

Other Equity Instruments • The company reported no warrants, convertibles, or other equity-linked agreements, and recorded no other movements in issued or treasury shares.

The absence of equity movements underscores a stable capital structure for Bayzed Health in March 2026, with full regulatory compliance affirmed in the latest filing.